344860 — Innogene Co Balance Sheet
0.000.00%
- KR₩27bn
- KR₩13bn
- KR₩9bn
- 92
- 37
- 61
- 72
Annual balance sheet for Innogene Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 717 | 2,818 | 3,198 | 13,072 | 13,344 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 781 | 1,011 | 1,066 | 995 | 845 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,648 | 5,065 | 6,216 | 15,476 | 16,007 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,635 | 1,519 | 1,445 | 1,412 | 1,296 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 4,390 | 6,668 | 7,949 | 17,200 | 17,545 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,157 | 1,176 | 1,175 | 1,144 | 933 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,243 | 1,263 | 1,205 | 1,174 | 933 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 3,147 | 5,405 | 6,744 | 16,026 | 16,613 |
Total Liabilities & Shareholders' Equity | 4,390 | 6,668 | 7,949 | 17,200 | 17,545 |
Total Common Shares Outstanding |